Inventor
REGULA JOERG THOMAS
DE48 patents
⚠️ This page may combine multiple inventors who share the name “REGULA JOERG THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
33 patentsUS11306154B2Apr 19, 2022
Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer
HOFFMANN LA ROCHE13 citations94
US11267903B2Mar 8, 2022
Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer
HOFFMANN LA ROCHE17 citations94
US10392445B2Aug 27, 2019
Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules
HOFFMANN LA ROCHE31 citations93
US9914776B2Mar 13, 2018
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE16 citations92
US9708396B2Jul 18, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies
HOFFMANN LA ROCHE16 citations92
US8361747B2Jan 29, 2013
Antibodies against human angiopoietin 2
HOFFMANN LA ROCHE10 citations92
US11603411B2Mar 14, 2023
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE9 citations85
US10941205B2Mar 9, 2021
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE10 citations85
US11091541B2Aug 17, 2021
Human FcRn-binding modified antibodies and methods of use
HOFFMANN LA ROCHE6 citations84
US10611841B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US10611840B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US9340609B2May 17, 2016
Antibodies against human angiopoietin 2
HOFFMANN LA ROCHE3 citations84
US10287352B2May 14, 2019
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE10 citations82
US7625996B2Dec 1, 2009
Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
HOFFMANN LA ROCHE14 citations82
US11673945B2Jun 13, 2023
Bispecific antigen binding proteins
HOFFMANN LA ROCHE4 citations75
US11117965B2Sep 14, 2021
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE2 citations73
US10640555B2May 5, 2020
Bispecific antigen binding proteins
HOFFMANN LA ROCHE2 citations73
US11787868B2Oct 17, 2023
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations72
US10611825B2Apr 7, 2020
Monovalent antigen binding proteins
HOFFMANN LA ROCHE6 citations72
US10538585B2Jan 21, 2020
Anti-ANG2 antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US11130810B2Sep 28, 2021
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE4 citations71
US10730938B2Aug 4, 2020
Bispecific antibodies and methods of use in ophthalmology
HOFFMANN LA ROCHE3 citations71
US10087246B2Oct 2, 2018
Anti-PDGF-B antibodies and methods of use
HOFFMANN LA ROCHE2 citations71
US11958912B2Apr 16, 2024
Method for determining the in vivo interaction mode
HOFFMANN LA ROCHE2 citations70
US12264196B2Apr 1, 2025
Fc-receptor binding modified asymmetric antibodies and methods of use
HOFFMANN LA ROCHE1 citations64
US12441812B2Oct 14, 2025
Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules
HOFFMANN LA ROCHE0 citations62
US12358997B1Jul 15, 2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies
HOFFMANN LA ROCHE0 citations62
US12030952B2Jul 9, 2024
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations62
US10766967B2Sep 8, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE1 citations62
US12391757B2Aug 19, 2025
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE0 citations61
US9073986B2Jul 7, 2015
Antibodies against human angiopoietin 2
HOFFMANN LA ROCHE0 citations52
US10793621B2Oct 6, 2020
Nucleic acid encoding dual Fc antigen binding proteins
HOFFMANN LA ROCHE0 citations51
US9724425B2Aug 8, 2017
Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)
HOFFMANN LA ROCHE0 citations48
BRINKMANN ULRICH
5 patentsUS9382323B2Jul 5, 2016
Multispecific antibodies comprising full length antibodies and single chain fab fragments
BRINKMANN ULRICH77 citations97
US8133979B2Mar 13, 2012
Antibodies against human angiopoietin 2
BRINKMANN ULRICH19 citations92
US8399626B2Mar 19, 2013
Antibodies against human angiopoietin 2
BRINKMANN ULRICH9 citations83
US10106600B2Oct 23, 2018
Bispecific antibodies
BRINKMANN ULRICH2 citations71
US9109027B2Aug 18, 2015
Antibodies against human angiopoietin 2
BRINKMANN ULRICH2 citations62
ROCHE GLYCART AG
2 patentsUS9695233B2Jul 4, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
ROCHE GLYCART AG44 citations97
US10683345B2Jun 16, 2020
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
ROCHE GLYCART AG5 citations72